Hedge Fund and Insider Trading News: David Einhorn, Ken Fisher, Tom Steyer, Jim Simons, QAD Inc. (QADA), Chesapeake Energy Corporation (CHK), and More
Billionaire Ken Fisher made his name and fortune picking stocks.
Posts Tagged ‘Ampio Pharmaceuticals Inc. (AMPE)’
Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE)
Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) has recently reported topline from its PIVOT trial and the stock lost over 60% on the announcement last Thursday.
Here’s Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks
Stocks are trading in the green on Thursday as markets continue to steadily recover from the Brexit-triggered wild swings.
Trellus Management’s Top Biotech Stock Picks For Q4
Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994.
Hi-Shakers News: Ampio Pharmaceuticals Inc (AMPE) Climbs, YY Inc (ADR) (YY) Added to Watch List, Sandstorm Gold Ltd. (SAND) Deal with Premier Royalty
Shares of Ampio Pharmaceuticals Inc. jumped Wednesday after the company said its drug Ampion reduced knee pain caused by osteoarthritis in a recent study.
Roche Holding Ltd. (ADR) (RHHBY), Novartis AG (ADR) (NVS): Should You Keep an Eye on These Eye Treatment Biotechs?
Investors might want to keep their eyes on the eye care industry, as the battle for eye treatments heats up across the biotech sector.
AcelRx Pharmaceuticals Inc (ACRX): Insiders Are Buying, Should You?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a first-rate investment today? Hedge funds are getting less optimistic.
Regeneron Pharmaceuticals Inc (REGN): Is This Eye Drug Worth The Hype?
Editor’s Note: The original article incorrectly references Lucentis’ and Eylea’s dosage instructions and Roche's vaccine market share.
Regeneron Pharmaceuticals Inc (REGN): Is This Eye Drug Worth The Hype?
Editor’s Note: The original article incorrectly references Lucentis’ and Eylea’s dosage instructions.
Hedge Funds Are Betting On Horizon Pharma Inc (HZNP)
To most investors, hedge funds are seen as slow, old investment tools of years past.
Regeneron Pharmaceuticals Inc (REGN), Ampio Pharmaceuticals, Inc. (AMPE): Is This Eye Drug Worth The Hype?
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) should spike– every time there’s a slight pullback the stock shoots higher.
Hedge Funds Are Crazy About Zogenix, Inc. (ZGNX)
In today’s marketplace, there are a multitude of gauges shareholders can use to analyze the equity markets.
